Macitentan
- Product NDC
- 62332-373
- Requested package NDC
- 62332-373-30
- 11-digit product format
- 623320373
- Labeler code
- 62332
- Product ID
- 62332-373_474cbf43-5f14-4bbb-b3c9-0cbc575fd506
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Macitentan
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA211128
- Marketing category
- ANDA
- Marketing start
- 2026-06-06
- Substance
- MACITENTAN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211128-001 | MACITENTAN | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211128-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211128-001 | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A211128-001 | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211128-001 | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211128-001 | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211128-001 | MACITENTAN | 10MG | TABLET / ORAL | AB | 2025-08-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211128-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A211128-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211128-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211128-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211128-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Macitentan
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MACITENTAN | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| Z9K9Y9WMVL | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1442137 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98b3309a-5012-42b5-b773-a38c2f52296c | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Macitentan | MACITENTAN | Alembic Pharmaceuticals Limited | 4d9d9a84-6853-4004-b20a-8849b34453a4 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 211128 ANDA211128 |
| Macitentan | MACITENTAN | Alembic Pharmaceuticals Inc. | 98b3309a-5012-42b5-b773-a38c2f52296c | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 211128 ANDA211128 62332-373-30 62332-373 62332037330 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 62332-373-30 | 62332037330 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-373-30) | 2026-06-06 | No | No | Current |